EUVIMEDEUVIMED entdecken
Crossref

Commentary on Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement

Maciej Krzakowski

Oncology in Clinical Practice · 2024

DOI: 10.5603/ocp.100207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology in Clinical Practice, 2024. Verfasst von Maciej Krzakowski.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Krzakowski, M. (2024). Commentary on Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement. Oncology in Clinical Practice. https://doi.org/10.5603/ocp.100207

Vancouver

Krzakowski M. Commentary on Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement. Oncology in Clinical Practice. 2024. doi:10.5603/ocp.100207

BibTeX
@article{Krzakowski2024,
  author = {Krzakowski, Maciej},
  title = {Commentary on Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement},
  journal = {Oncology in Clinical Practice},
  year = {2024},
  doi = {10.5603/ocp.100207}
}
Kostenlos starten →